Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics

M. S. Didolkar, A. J. Jackson, D. G. Covell, A. P. Walker, N. D. Eddington

Research output: Contribution to journalArticle

Abstract

Continuous infusion chemotherapy via hepatic artery using newly available mechanical devices is frequently used to treat hepatic metastases to achieve a high concentration of 5-florouracil (5-FUra) in the hepatic circulation while minimizing systemic exposure. We compared four routes or intrahepatic adminstration to find out the best one in the canine model. To ascertain this date, 5-FUra (30 mg/kg) was given as a continuous infusion over a 3 hr period into either a systemic vein (femoral), portal vein, hepatic artery, or hepatic artery distal to its ligation after hepatic dearterialization. A total of eight dogs were studied. During 5-FUra infusion, concomitant blood samples were taken from the inferior vena cava and hepatic vein at 1, 2, 3, 5, 10, 15, 30, 60, 120, and 180 min. 5-FUra levels were determined in plasma by high-performance liquid chromatography. Blood flow in the portal vein and hepatic artery was measured by an electromagnetic flowmeter. The data described by a multicompartmental model, including the measured flows, had separate hepatic arterial and portal compartments with elimination from each described by linear kinetics. Mean area under the curve values in μg/ml x min and the ratios of the systemic/hepatic vein areas following 5-FUra infusion via systemic, portal vein, hepatic artery, or hepatic artery after dearterialization routes were: 975/539 (R = 1.80), 939/748 (R = 1.35), 211/454 (R = 0.46), and 562/1,424 (R = 0.39). The results indicated that the administration of 5-FUra via the hepatic arterial route distal to its ligation results in the highest hepatic vein drug levels with the smallest systemic/hepatic vein exposure ratio , followed by intra-arterial route, while systemic and portal vein routes were not nearly as advantageous as the intra-arterial routes.

Original languageEnglish (US)
Pages (from-to)187-193
Number of pages7
JournalJournal of Surgical Oncology
Volume41
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Hepatic Artery
Fluorouracil
Hepatic Veins
Pharmacokinetics
Portal Vein
Liver
Ligation
Liver Circulation
Flowmeters
Femoral Vein
Electromagnetic Phenomena
Inferior Vena Cava
Area Under Curve
Canidae
High Pressure Liquid Chromatography
Dogs
Neoplasm Metastasis
Drug Therapy
Equipment and Supplies
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Didolkar, M. S., Jackson, A. J., Covell, D. G., Walker, A. P., & Eddington, N. D. (1989). Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics. Journal of Surgical Oncology, 41(3), 187-193.

Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics. / Didolkar, M. S.; Jackson, A. J.; Covell, D. G.; Walker, A. P.; Eddington, N. D.

In: Journal of Surgical Oncology, Vol. 41, No. 3, 1989, p. 187-193.

Research output: Contribution to journalArticle

Didolkar, MS, Jackson, AJ, Covell, DG, Walker, AP & Eddington, ND 1989, 'Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics', Journal of Surgical Oncology, vol. 41, no. 3, pp. 187-193.
Didolkar, M. S. ; Jackson, A. J. ; Covell, D. G. ; Walker, A. P. ; Eddington, N. D. / Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics. In: Journal of Surgical Oncology. 1989 ; Vol. 41, No. 3. pp. 187-193.
@article{cda27b590f634f278a1564f6608c3b00,
title = "Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics",
abstract = "Continuous infusion chemotherapy via hepatic artery using newly available mechanical devices is frequently used to treat hepatic metastases to achieve a high concentration of 5-florouracil (5-FUra) in the hepatic circulation while minimizing systemic exposure. We compared four routes or intrahepatic adminstration to find out the best one in the canine model. To ascertain this date, 5-FUra (30 mg/kg) was given as a continuous infusion over a 3 hr period into either a systemic vein (femoral), portal vein, hepatic artery, or hepatic artery distal to its ligation after hepatic dearterialization. A total of eight dogs were studied. During 5-FUra infusion, concomitant blood samples were taken from the inferior vena cava and hepatic vein at 1, 2, 3, 5, 10, 15, 30, 60, 120, and 180 min. 5-FUra levels were determined in plasma by high-performance liquid chromatography. Blood flow in the portal vein and hepatic artery was measured by an electromagnetic flowmeter. The data described by a multicompartmental model, including the measured flows, had separate hepatic arterial and portal compartments with elimination from each described by linear kinetics. Mean area under the curve values in μg/ml x min and the ratios of the systemic/hepatic vein areas following 5-FUra infusion via systemic, portal vein, hepatic artery, or hepatic artery after dearterialization routes were: 975/539 (R = 1.80), 939/748 (R = 1.35), 211/454 (R = 0.46), and 562/1,424 (R = 0.39). The results indicated that the administration of 5-FUra via the hepatic arterial route distal to its ligation results in the highest hepatic vein drug levels with the smallest systemic/hepatic vein exposure ratio , followed by intra-arterial route, while systemic and portal vein routes were not nearly as advantageous as the intra-arterial routes.",
author = "Didolkar, {M. S.} and Jackson, {A. J.} and Covell, {D. G.} and Walker, {A. P.} and Eddington, {N. D.}",
year = "1989",
language = "English (US)",
volume = "41",
pages = "187--193",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics

AU - Didolkar, M. S.

AU - Jackson, A. J.

AU - Covell, D. G.

AU - Walker, A. P.

AU - Eddington, N. D.

PY - 1989

Y1 - 1989

N2 - Continuous infusion chemotherapy via hepatic artery using newly available mechanical devices is frequently used to treat hepatic metastases to achieve a high concentration of 5-florouracil (5-FUra) in the hepatic circulation while minimizing systemic exposure. We compared four routes or intrahepatic adminstration to find out the best one in the canine model. To ascertain this date, 5-FUra (30 mg/kg) was given as a continuous infusion over a 3 hr period into either a systemic vein (femoral), portal vein, hepatic artery, or hepatic artery distal to its ligation after hepatic dearterialization. A total of eight dogs were studied. During 5-FUra infusion, concomitant blood samples were taken from the inferior vena cava and hepatic vein at 1, 2, 3, 5, 10, 15, 30, 60, 120, and 180 min. 5-FUra levels were determined in plasma by high-performance liquid chromatography. Blood flow in the portal vein and hepatic artery was measured by an electromagnetic flowmeter. The data described by a multicompartmental model, including the measured flows, had separate hepatic arterial and portal compartments with elimination from each described by linear kinetics. Mean area under the curve values in μg/ml x min and the ratios of the systemic/hepatic vein areas following 5-FUra infusion via systemic, portal vein, hepatic artery, or hepatic artery after dearterialization routes were: 975/539 (R = 1.80), 939/748 (R = 1.35), 211/454 (R = 0.46), and 562/1,424 (R = 0.39). The results indicated that the administration of 5-FUra via the hepatic arterial route distal to its ligation results in the highest hepatic vein drug levels with the smallest systemic/hepatic vein exposure ratio , followed by intra-arterial route, while systemic and portal vein routes were not nearly as advantageous as the intra-arterial routes.

AB - Continuous infusion chemotherapy via hepatic artery using newly available mechanical devices is frequently used to treat hepatic metastases to achieve a high concentration of 5-florouracil (5-FUra) in the hepatic circulation while minimizing systemic exposure. We compared four routes or intrahepatic adminstration to find out the best one in the canine model. To ascertain this date, 5-FUra (30 mg/kg) was given as a continuous infusion over a 3 hr period into either a systemic vein (femoral), portal vein, hepatic artery, or hepatic artery distal to its ligation after hepatic dearterialization. A total of eight dogs were studied. During 5-FUra infusion, concomitant blood samples were taken from the inferior vena cava and hepatic vein at 1, 2, 3, 5, 10, 15, 30, 60, 120, and 180 min. 5-FUra levels were determined in plasma by high-performance liquid chromatography. Blood flow in the portal vein and hepatic artery was measured by an electromagnetic flowmeter. The data described by a multicompartmental model, including the measured flows, had separate hepatic arterial and portal compartments with elimination from each described by linear kinetics. Mean area under the curve values in μg/ml x min and the ratios of the systemic/hepatic vein areas following 5-FUra infusion via systemic, portal vein, hepatic artery, or hepatic artery after dearterialization routes were: 975/539 (R = 1.80), 939/748 (R = 1.35), 211/454 (R = 0.46), and 562/1,424 (R = 0.39). The results indicated that the administration of 5-FUra via the hepatic arterial route distal to its ligation results in the highest hepatic vein drug levels with the smallest systemic/hepatic vein exposure ratio , followed by intra-arterial route, while systemic and portal vein routes were not nearly as advantageous as the intra-arterial routes.

UR - http://www.scopus.com/inward/record.url?scp=0024356628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024356628&partnerID=8YFLogxK

M3 - Article

C2 - 2747244

AN - SCOPUS:0024356628

VL - 41

SP - 187

EP - 193

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -